IVIG in autoimmune disease—Potential next generation biologics

AW Zuercher, R Spirig, AB Morelli, F Käsermann - Autoimmunity reviews, 2016 - Elsevier
Polyclonal plasma-derived IgG is a mainstay therapeutic of immunodeficiency disorders as
well as of various inflammatory autoimmune diseases. In immunodeficiency the primary …
被引用次数：75 相关文章

IVIG in autoimmune disease—Potential next generation biologics

AW Zuercher, R Spirig, AB Morelli, F Käsermann - Autoimmunity Reviews, 2016 - infona.pl
Polyclonal plasma-derived IgG is a mainstay therapeutic of immunodeficiency disorders as
well as of various inflammatory autoimmune diseases. In immunodeficiency the primary …

IVIG in autoimmune disease-Potential next generation biologics

AW Zuercher, R Spirig, AB Morelli… - Autoimmunity …, 2016 - pubmed.ncbi.nlm.nih.gov
Polyclonal plasma-derived IgG is a mainstay therapeutic of immunodeficiency disorders as
well as of various inflammatory autoimmune diseases. In immunodeficiency the primary …

IVIG in autoimmune disease-Potential next generation biologics.

AW Zuercher, R Spirig, F Käsermann - Autoimmunity Reviews, 2016 - europepmc.org
Polyclonal plasma-derived IgG is a mainstay therapeutic of immunodeficiency disorders as
well as of various inflammatory autoimmune diseases. In immunodeficiency the primary …